'Consolidated net sales (including other
operating income) of P I Industries has increased 8.30% to Rs 2068.9
crore. Domestic revenues were subdued
mainly due to delayed sowing and erratic spread of monsoon although favourable
product mix and improved working capital management helped in containing the
financial impact. 14% growth in Agchem Exports was mainly driven by volumes and
growth of new products. New products growth was around 24% YoY. Pharma
contributed lower exports revenue of Rs. 25.3 crore due to supply deferment of
a few products.
Sales of Agro Chemicals segment has gone up
9.53% to Rs 2,043.90 crore (accounting for 98.78% of total sales).
Sales of Pharma segment has gone down 42.89%
to Rs 25.30 crore (accounting for 1.22% of total sales).
Profit before interest, tax and other
unallocable items (PBIT) has jumped 27.14% to Rs 566.30 crore.
PBIT of Agr...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|